Last edition
News about "Cidara Therapeutics"
Merck Completes Acquisition of Cidara Therapeutics to Strengthen Influenza Pipeline
Merck, known as MSD outside the United States and Canada, has announced the successful completion of its cash tender offer, through a subsidiary, to acquire Cidara Therapeutics, Inc.
Cidara Therapeutics | 07/01/2026 | By Darshana | 250
Merck Poised to Acquire Cidara Therapeutics in Deal Valued Above USD 3.3 Billion
Merck & Co. is reportedly closing in on the acquisition of Cidara Therapeutics, a biotechnology company focused on long-acting antibody treatments for influenza. The deal is expected to value Cidara above its USD 3.3 billion market capitalisation.
Cidara Therapeutics | 14/11/2025 | By Darshana | 135
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy